ARTICLE | Finance
Feb. 11 Quick Takes: LSP closes Europe’s largest-ever VC fund at €1 billion
Plus: Regeneron testing high doses of Eylea and updates from the EIB, EdiGene and more
February 12, 2022 3:52 AM UTC
LSP announced a final close for its flagship fund LSP 7 at €1 billion ($1.1 billion), the hard cap for what is to date the largest life sciences fund ever raised in Europe. The fund counts five pharma companies as strategic LPs, including four from Asia.
The VC announced the first close back in November at €850 million ($982.9 million) in parallel with a deal in which private equity firm EQT AB (SSE:EQT) agreed to acquire LSP, allowing the life sciences firm to grow its funds and focus on investments. The deal is expected to close this quarter, after which LSP will be known as EQT Life Sciences...